The Food and Drug Administration (FDA) is the U.S. agency that sets and enforces the legal obligations for the food and pharmaceutical industries. This article looks at what the FDA does, why its approval process draws criticism and whether the U.S. could work without the FDA.
If you run a pharmacy or own a pharmaceutical brand, you need to keep close track of your drugs, their ingredients, and their packaging and labeling. That raises common questions. What is FDA regulatory compliance? What happens if you don’t comply? And what would happen if the FDA did not exist?
What does the FDA regulate?
The FDA’s main responsibilities include oversight of drugs, their side effects, their ingredients, and their packaging and labeling. The products it regulates directly affect health care for the general public, and the agency can raise or change standards for what goes into a drug and how it affects people.
Before a drug reaches the market, the FDA reviews the company’s research data and weighs the benefits against the risks. If the data shows a real chance of unwarranted side effects, the drug can be held back from the public.
Why do some people criticize the FDA?
Some companies, and some patients with life-threatening diseases, see this power as too strict. Critics argue that patients do not get to decide for themselves whether a drug’s risks are worth taking. A drug that harms 90 percent of people might still help the other 10 percent.
The other complaint is time. Reviews can take years, and critics say patients who are waiting for new treatments suffer or die in the meantime. Drugs for rare diseases face an extra hurdle, because the small number of patients makes them less attractive to develop.
The FDA has programs aimed at these concerns. It can grant orphan drug designation to products that prevent, diagnose or treat a rare disease, which gives sponsors incentives to develop them. Through expanded access, sometimes called compassionate use, a patient with a serious or immediately life-threatening condition may be able to get an unapproved drug outside a clinical trial when no satisfactory alternative exists.
What if private companies replaced the FDA?
In the U.S., people make their own personal and professional choices, and some private companies and doctors argue that choosing a drug to save a life should be no different. If another body replaced the FDA, private firms could enter the market with their own physicians and, of course, their own price tags.
The key question is whether those firms would test and monitor their own products as strictly as the FDA does. Would the drugs still work once they reached patients? Or would the results be the same as today, or worse? One likely benefit is that more drugs, and more choices, would reach the public sooner.
Does the FDA do more good than harm?
The FDA provides safety, but critics say its delays cost lives. Seen from a wider angle, though, the agency restricts or slows drugs because it is guaranteeing their safety. Few other organizations could match the depth of its evaluations and inspections.
Still, if people weighed drug risks for themselves, they might become more careful and better informed about their own health choices, and help raise awareness among others.
Key takeaways
The FDA reviews drugs for safety and effectiveness before they reach the public, and that protection comes at the cost of time. Whether its authority is too broad is a long-running debate. Considering the alternatives, from private oversight to more patient choice, is a reasonable part of that discussion.
Related Blogs
9 Ways to Improve Employee Engagement and Productivity at Work
Transforming Payments: Introducing FedNow - The Future of Real-Time Transactions
Related Industries
FDA Compliance
Medical Devices
Clinical Research
Audit Webinar
HR Compliance
Banking and Finance
Hospital and Healthcare
Packaging and Labeling
Accounting, Payroll and Taxation
Food and beverages
Software
Miscellaneous
Pharmaceutical